Cell-lines blog posts

12 August, 2019

Top 4 reasons to use peer-reviewed publications to support oncology model research

By Jamie Naden

Preclinical evaluation of a molecular compound and testing a therapeutic approach for a potential cancer treatment often relies on biomedical research with cancer cell lines. Selecting the most appropriate oncology cell line to support an experimental design and drug development strategy requires careful consideration of a number of factors to ensure the research provides robust results that can translate from in vitro to in vivo and ultimately into the clinic.

Peer-reviewed publications serve as an important component of the pre-planning process to stay up-to-date on the most current literature and findings about results generated from oncology cell lines. These references help researchers compare the advantages and drawbacks of using certain preclinical oncology models, understand potential risks and make more informed decisions in selecting a cell line for their preclinical studies.   

+ Read more